NEOS Investment Management LLC Increases Holdings in HCA Healthcare, Inc. $HCA

Key Points

• NEOS Investment Management increased its HCA Healthcare stake by 12% in the second quarter, ending with 25,349 shares valued at approximately $9.88 million. Institutional investors collectively own 62.73% of HCA’s outstanding stock.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $462.64, although several firms recently lowered their targets. HCA shares opened at $404.95, below their 200-day moving average.
• HCA exceeded quarterly expectations with adjusted earnings of $7.59 per share and revenue of $20.23 billion, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, representing a 0.8% annualized yield.

NEOS Investment Management LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,349 shares of the company's stock after acquiring an additional 2,724 shares during the quarter. NEOS Investment Management LLC's holdings in HCA Healthcare were worth $9,883,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of HCA. Sumitomo Life Insurance Co. increased its position in shares of HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock valued at $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV boosted its position in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock valued at $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC raised its holdings in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company's stock valued at $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its holdings in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after purchasing an additional 22 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Mizuho lowered their price target on HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating on the stock in a report on Tuesday, July 28th. TD Cowen dropped their target price on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating on the stock in a research report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft set a $476.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Weiss Ratings downgraded shares of HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, June 9th. Finally, UBS Group decreased their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Trading Down 1.0%

NYSE HCA opened at $404.95 on Friday. The company's 50 day moving average is $403.35 and its two-hundred day moving average is $437.55. The stock has a market cap of $87.67 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.33 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company's revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $6.84 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is currently 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source